Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1Phase 1 1

Status

Unknown 2Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Gastrointestinal 4Head & Neck 3

Conditions

Esophageal Neoplasms 2Rectal Neoplasms 1Pancreatic Neoplasms 1

Interventions

Oxaliplatin 1413Fluorouracil 1301Capecitabine 1087Gemcitabine 1045Leucovorin 932Irinotecan 818Bevacizumab 804Cisplatin 669Radiotherapy 536Cetuximab 470pembrolizumab 428Paclitaxel 390Nivolumab 337130-nm albumin-bound paclitaxel 325Drug Therapy 314Docetaxel 287S 1 (combination) 274Sorafenib 266Folfox protocol 261Albumin-Bound Paclitaxel 259sintilimab 211durvalumab 210Surgical Procedures, Operative 204tislelizumab 203Radiosurgery 202lenvatinib 201apatinib 200Carboplatin 187Magnetic Resonance Spectroscopy 183regorafenib 181

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × Chemoradiotherapy, Adjuvant × Gastrointestinal × Clear all
NCT05667298 2026-05-11

OPERARADIO

University of Manitoba

Phase 1 Active not recruiting
11 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT06427447 2025-02-04

ADJUPANC

Changhai Hospital

Phase 3 Recruiting
770 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT02371304 2020-05-21

TESAR

Amsterdam UMC, location VUmc

Phase 3 Unknown
302 enrolled
Gastrointestinal

Rectal Neoplasms

NCT01463501 2013-05-14

Neoadjuvant Versus Adjuvant Therapy in Treating Resectable Thoracic Esophageal Cancer

Zhejiang Cancer Hospital

Phase 2 Unknown
60 enrolled
Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡